CCL22 controls immunity by promoting regulatory T cell communication with dendritic cells in lymph nodes

Moritz Rapp, Maximilian W. M. Wintergerst, Wolfgang G. Kunz, +18

The Journal of Experimental Medicine

CCL1 is a major regulatory T cell attracting factor in human breast cancer

Benjamin Kuehnemuth, Ignazio Piseddu, Gabriela M. Wiedemann, +8

BMC Cancer

Lysosomal endonuclease RNase T2 and PLD exonucleases cooperatively generate RNA ligands for TLR7 activation

Marleen Bérouti, Katja Lammens, Larissa Hansbauer, +11

Immunity

Constitutive Expression of CCL22 Is Mediated by T Cell–Derived GM-CSF

Ignazio Piseddu, Natascha Röhrle, Maximilian M. L. Knott, +13

The Journal of Immunology

Outcome and management of patients with hepatocellular carcinoma who achieved a complete response to immunotherapy-based systemic therapy

Bernhard Scheiner, Beodeul KANG, Lorenz Balcar, +55

Hepatology

Pseudouridine RNA avoids immune detection through impaired endolysosomal processing and TLR engagement

Marleen Bérouti, Mirko Wagner, Wilhelm Greulich, +12

Cell

Mutation-specific CAR T cells as precision therapy for IGLV3-21R110 expressing high-risk chronic lymphocytic leukemia

Florian Märkl, Christoph Schultheiß, Murtaza Ali, +22

Nature Communications

Atezolizumab/bevacizumab or lenvatinib in hepatocellular carcinoma: Multicenter real-world study with focus on bleeding and thromboembolic events

Najib Ben Khaled, Marie Møller, Leonie Jochheim, +22

JHEP Reports

PD-1/PD-L1 immune checkpoint therapy demonstrates favorable safety profile in patients with autoimmune and cholestatic liver disease

Lorenz Kocheise, Ignazio Piseddu, Joscha Vonderlin, +22

Frontiers in Immunology

Extracorporeal photopheresis vs. systemic immunosuppression for immune-related adverse events: Interim analysis of a prospective two-arm study

Claudia Ertl, T. Ruf, Linda Hammann, +12

European Journal of Cancer